Aligos Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
ALGS
CUSIP
01626L204
Type
Equity
Class
COM NEW
Num filings
31
Total reported value, excl. options
$13.2 M
Manager Report Date Value ($000) Shares Option Type